Ozempic | Alpha Leaders

Browsing: Ozempic

Why These Investment Firms Bet $400 Million On A Chinese Ozempic Rival

By Press Room12 April 2025

Kailera jumped the weight loss miracle-drug line by licensing four clinical-stage obesity therapies from China, which is quickly emerging as…

The War And Treaty’s Michael Trotter, Jr.’s Type 2 Diabetes Change

By Press Room31 March 2025

“A Healing Tide” was the name of The War and Treaty’s 2018 debut album. But that could also describe what…

Super Bowl Ad Raises Questions About Compounded Versus Branded Obesity Meds

By Press Room7 February 2025

A commercial airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the…

The wealthy 1% are turning to new status symbols that can’t be bought—and it’s hurting Dior, Versace, and Burberry

By Press Room7 February 2025

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

By Press Room3 February 2025

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

By Press Room22 January 2025

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication…

Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions

By Press Room21 January 2025

Weight-loss drugs like Ozempic may offer health benefits far beyond those already flagged by research, a large-scale study suggests. Scientists…

Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease

By Press Room20 January 2025

Radical new proposal from 58 medical experts would decenter BMI from obesity diagnosis

By Press Room15 January 2025

Lilly’s Obesity Drug Zepbound To Be Key Health Cost Driver For 2025

By Press Room1 January 2025

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health…

What's On

How HR leaders can talk employees through volatile economic times

Trump’s Dilemma: A Trade War That Threatens Every Other Negotiation With China

Why Japan’s Emerging Carbon Market Could Reshape Global Trading

Browsing: Ozempic

Why These Investment Firms Bet $400 Million On A Chinese Ozempic Rival

The War And Treaty’s Michael Trotter, Jr.’s Type 2 Diabetes Change

Super Bowl Ad Raises Questions About Compounded Versus Branded Obesity Meds

The wealthy 1% are turning to new status symbols that can’t be bought—and it’s hurting Dior, Versace, and Burberry

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

Weight-Loss Drugs Like Ozempic Linked To Lower Risk Of 42 Conditions

Largest-ever Ozempic and GLP-1 drug study finds they lower risk of 42 health conditions, including heart attacks and Alzheimer’s disease

Radical new proposal from 58 medical experts would decenter BMI from obesity diagnosis

Lilly’s Obesity Drug Zepbound To Be Key Health Cost Driver For 2025

Unwrap Christmas Sustainably: How To Handle Gifts You Don’t Want

Walmart dominated, while Target spiraled: the winners and losers of retail in 2024

Starbucks’ new CEO has a long to-do list—moving the HQ out of Seattle is not at the top

Trump’s Give-and-Take Tariff Strategy

DOGE Big Balls Ransomware Attack — What You Need To Know

The White House pressed for fast negotiations with its shock and awe tariffs. Now it can’t drum up enough interest from a ‘first mover’

A Scientist Is Paid to Study Maple Syrup. He’s Also Paid to Promote It.

Our Picks

How HR leaders can talk employees through volatile economic times

Trump’s Dilemma: A Trade War That Threatens Every Other Negotiation With China

Why Japan’s Emerging Carbon Market Could Reshape Global Trading

Most Popular

Mark Zuckerberg’s showdown with the FTC is massive for Meta—and even bigger for tech overall

Trump’s Give-and-Take Tariff Strategy

DOGE Big Balls Ransomware Attack — What You Need To Know